Press Releases

SAN FRANCISCO, Nov. 3, 2019 /PRNewswire/ -- The Breakthrough Prize celebrated recipients of its 2020 Breakthrough Prize at a glittering awards ceremony at the NASA Ames Research Center in Mountain View, broadcast live on National Geographic. Renowned as the "Oscars of Science," the awards brought together luminaries i

ESPOO, Finland, Nov. 4, 2019 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions for global industries, expands its selection of biocompatible ALD materials to be used in medical applications.Picosun's TiO2 and Al2O3 processes are already used in pro

NEW YORK, Nov. 3, 2019 /PRNewswire/ -- ClinicAll International Corporation is excited to announce the strategic partnership with The Private Office of Sheikh Saeed Bin Ahmed Al Maktoum and SEED Group.

Oligomannate , A New Oral Treatment For Mild To Moderate Alzheimer's Disease The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 2, 2019 /PRNewswire/ -- Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products Admini

NEW YORK, Nov. 1, 2019 /PRNewswire/ -- The Brooklyn Hospital Center (the "Hospital") is a full-service community teaching hospital located in Brooklyn, New York. The Hospital is providing notice of a recent data security incident that may affect the security of personal information in our care. We have no evidence of actual

BURGWEDEL, Germany, Nov. 1, 2019 /PRNewswire/ -- MYR Pharmaceuticals today announced the presentation of a number of results on bulevirtide at the upcoming meeting of American Association for the Study of Liver Diseases (AASLD), in Boston, US.The results of 48 weeks administration of bulevirtide (Myrcludex), MYR`s first-in-cla

WASHINGTON, Nov. 1, 2019 /PRNewswire/ -- The Center for Lyme Action today applauded the U.S. Senate Health, Education, Labor and Pensions Committee for advancing critical legislation to improve prevention, early detection and treatment of Lyme and other tick-borne diseases.The

PORT WASHINGTON, N.Y., Nov. 1, 2019 /PRNewswire/ -- A former, top executive for Juul Labs, Inc. has filed a lawsuit against Juul Labs, Inc.   In the

SOUTH SAN FRANCISCO, Calif., Nov. 1, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) announced today that on October 31, 2019, the Compensation Committee of the Board of Directors approved, effective as of October 31, 2019, the grant to six new employees of (i) inducement stock

NEW HAVEN, Conn., Nov. 1, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended September 30, 2019, and